Skip to main content
Premium Trial:

Request an Annual Quote

USPTO Allows Claims in Regulus Patent Application on miR-155

Premium

Regulus Therapeutics said this week that the US Patent and Trademark Office has allowed claims in a US patent application relating to human microRNA-155, a potential target for immuno-inflammatory disorders and part of a lead program in the company's collaboration with GlaxoSmithKline.

The claims also cover sequences of miR-155, as well as compounds that are complementary to the miRNA, Regulus said.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.